Vincristine + 5-Fluorouracil (5-FU)

Treatment for Hepatoblastoma

Typical Dosage: Vincristine 1.5-2 mg/m2; 5-FU 500 mg/m2

Effectiveness
60%
Safety Score
30%
Clinical Trials
5
Participants
3K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
30
DangerousModerateSafe
Treatment Details
Dosage Range
Vincristine 1.5-2 mg/m2; 5-FU 500 mg/m2
Time to Effect
weeks
Treatment Duration
Variable, often in specific protocols
Evidence Quality
MODERATE
Confidence Score
70%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$1,000
Monitoring:$5,000
Side Effect Mgmt:$7,000
Total Annual:$13,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATE
QALYs Gained
8
Outcome-Based Costs
Cost per Responder
$32,500
Cost per Remission
$32,500
Vincristine + 5-Fluorouracil (5-FU) Outcomes

for Hepatoblastoma

Efficacy Outcomes
Overall Effectiveness
+60%
Response Rate
+40%
Remission Rate
+40%
Common Side Effects
Peripheral neuropathy (Vincristine)
+60%
Myelosuppression (5-FU)
+60%
Mucositis (5-FU)
+45%
Constipation (Vincristine)
+40%
Diarrhea (5-FU)
+40%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
4 active trials recruiting for Vincristine + 5-Fluorouracil (5-FU) in Hepatoblastoma

Paediatric Hepatic International Tumour Trial

NCT03017326ACTIVE NOT RECRUITINGPHASE3
View Study
450 participants
INTERVENTIONAL
Vienna, Austria +31 more
Started: Aug 24, 2017

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

NCT00980460ACTIVE NOT RECRUITINGPHASE3
View Study
236 participants
INTERVENTIONAL
Birmingham, United States +208 more
Started: Sep 14, 2009

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

NCT04478292RECRUITINGPHASE3
View Study
330 participants
INTERVENTIONAL
Shanghai, China
Started: Mar 1, 2021

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

NCT03533582ACTIVE NOT RECRUITINGPHASE3
View Study
537 participants
INTERVENTIONAL
Birmingham, United States +204 more
Started: May 24, 2018
Completed Clinical Trials
1 completed trial for Vincristine + 5-Fluorouracil (5-FU) in Hepatoblastoma

Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer

NCT00003994COMPLETEDPHASE3
View Study
277 participants
INTERVENTIONAL
Arcadia, United States
Started: Mar 1, 1999